CYRAMZA 10 mg/mL
ramucirumab · SOLUTION · Eli Lilly and Company
No Recall History
Plain English
CYRAMZA is a solution containing ramucirumab at 10 mg/mL, taken intravenous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- CYRAMZA
- Generic Name
- ramucirumab
- NDC Code (Product)
0002-7669- Manufacturer
- Eli Lilly and Company
- Strength
- 10 mg/mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125477
- Drug Class
- Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
- Marketing Start
- 04/21/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is CYRAMZA used for?
CYRAMZA contains ramucirumab. It is a solution taken intravenous. Consult your doctor for specific uses.
Is CYRAMZA a controlled substance?
CYRAMZA is not classified as a controlled substance by the DEA.
What is the generic name for CYRAMZA?
The generic name for CYRAMZA is ramucirumab. There are no other listed brand versions of ramucirumab.
What is the NDC code for CYRAMZA 10 mg/mL?
The NDC (National Drug Code) for CYRAMZA 10 mg/mL is 0002-7669, listed by Eli Lilly and Company.
Other CYRAMZA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)